Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
May 10th, 2022
2.5K views
Group 2 innate lymphoid cells (ILC2s), implicated in type 2 inflammation, mainly participate in response to helminth infection, allergic diseases, metabolic homeostasis, and tissue repair. In this study, a procedure to isolate ILC2s from murine nasal mucosa and detect the expression of CD226 is demonstrated.
Overview
This study presents a protocol for isolating group 2 innate lymphoid cells (ILC2s) from murine nasal mucosa. The technique allows for the detection of CD226 expression, contributing to the understanding of ILC2s in nasal diseases.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Allergy Research
Background
- ILC2s are involved in type 2 inflammation.
- They play roles in helminth infection and allergic diseases.
- Understanding ILC2s can aid in developing treatments for nasal diseases.
- Isolation techniques are crucial for studying these cells.
Purpose of Study
- To isolate ILC2s from murine nasal mucosa.
- To explore the expression of CD226 on ILC2s.
- To investigate the role of ILC2s in nasal diseases.
Methods Used
- Isolation of ILC2s from murine nasal mucosa.
- Flow cytometry to detect surface antigen expression.
- Establishment of an allergic rhinitis model using ovalbumin.
- Intranasal instillation of ovalbumin for challenge.
Main Results
- Successful isolation of ILC2s from nasal mucosa.
- Detection of CD226 expression on isolated ILC2s.
- Establishment of a reliable allergic rhinitis model.
- Insights into the role of ILC2s in nasal inflammation.
Conclusions
- The protocol effectively isolates ILC2s for study.
- ILC2s play a significant role in nasal diseases.
- Further research can lead to therapeutic advancements.
Frequently Asked Questions
What are innate lymphoid cells?
Innate lymphoid cells (ILCs) are a group of immune cells that play a crucial role in the body's immune response, particularly in inflammation and tissue repair.
How are ILC2s isolated from nasal mucosa?
ILC2s are isolated using a specific protocol that involves careful dissection and flow cytometry to identify and characterize the cells.
What is the significance of CD226 expression?
CD226 is a surface marker that can indicate the activation state and functional capabilities of ILC2s, providing insights into their role in immune responses.
What model is used to study allergic rhinitis?
The allergic rhinitis model is established using ovalbumin, which is administered to induce an allergic response in mice.
Why is it important to study ILC2s?
Studying ILC2s is important for understanding their role in allergic diseases and developing potential therapeutic strategies.
Executive Industry Relevance
Precise isolation and phenotyping of group 2 innate lymphoid cells (ILC2s) from mouse nasal mucosa enables targeted investigation of immune mechanisms underlying allergic rhinitis and related pathologies. Quantitative detection of CD226 expression on ILC2s provides a foundation for mechanistic de-risking and target validation in early immunology discovery. This protocol supports translational continuity by enabling reproducible immune cell profiling in disease-relevant tissue contexts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of ILC2-mediated pathways in nasal mucosal immunity.
- Supports functional target validation by quantifying CD226 expression on ILC2s.
- Facilitates mechanistic de-risking for immune modulation strategies in allergic diseases.
- Provides a platform for hypothesis-driven exploration of ILC2 roles in disease onset.
Screening & Assay Development
- Delivers validated cell populations for downstream flow cytometry and in vitro assays.
- Standardizes cell isolation and staining for reproducible quantitative readouts.
- Enables robust comparison of immune cell phenotypes across healthy and disease models.
- Prepares samples suitable for assay development targeting ILC2 surface markers.
Translational & Preclinical Research
- Aligns immune cell profiling with disease-relevant nasal mucosa models.
- Supports continuity from discovery through preclinical validation of immune targets.
- Enables risk-adjusted advancement of immunomodulatory candidates based on tissue-specific data.
- Provides translational biomarker insights for allergic rhinitis and related disorders.
Pipeline & Workflow Integration
This method integrates into the immunology discovery continuum, bridging early target validation with preclinical immune profiling in disease-relevant models.
- Discovery Biology: Supports hypothesis testing on ILC2 function and CD226-mediated signaling in nasal mucosa.
- Screening: Provides standardized, reproducible cell populations for quantitative flow cytometry assays.
- Analytics: Enables measurement of ILC2 abundance and CD226 expression for comparative analysis between healthy and disease states.
- Translational Research: Connects immune cell phenotyping to preclinical models of allergic rhinitis.
- Enterprise Reuse: Establishes a reusable protocol for immune cell isolation and characterization in mucosal tissues.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in immune target selection and mechanistic understanding.
- Operational Value: Delivers standardized, scalable, and reproducible immune cell isolation workflows.
- Strategic Value: Improves go/no-go decisions for immunology programs by reducing biological ambiguity.
- Portfolio Impact: Enables risk-adjusted prioritization of immune targets and pathways for advancement.
Implementation Considerations
- Requires expertise in murine dissection, tissue processing, and flow cytometry analysis.
- Demands access to high-quality cytometry instrumentation and validated antibody panels.
- Necessitates rigorous cross-team standardization of tissue handling and staining protocols.
- Adaptation may be needed for other mucosal or tissue-specific immune cell populations.
- Careful removal of adjacent tissues and precise gradient centrifugation are critical for purity and reproducibility.
Biopharma FAQs
Why does null hypothesis testing matter for ILC2 CD226 expression?
Null hypothesis testing enables objective evaluation of whether observed differences in CD226 expression on ILC2s between healthy and allergic rhinitis mice are statistically significant. This supports robust target validation and reduces the risk of false-positive mechanistic claims in early discovery.
How does independent variable isolation fit the ILC2 nasal mucosa workflow?
Isolating ILC2s from nasal mucosa allows researchers to control for tissue-specific variables and directly assess the impact of disease state or experimental manipulation on immune cell phenotype. This strengthens mechanistic de-risking and supports reproducible discovery-stage findings.
What do quantitative flow cytometry measurements of CD226 enable?
Quantitative flow cytometry provides precise measurement of CD226 expression levels on ILC2s, enabling comparative analysis across experimental groups and supporting data-driven decisions in target validation and assay development.
Why are replication requirements critical for cross-functional immune profiling?
Replication ensures that observed differences in ILC2 abundance and CD226 expression are reproducible and not due to technical or biological variability, facilitating reliable data sharing and decision-making across discovery and translational teams.
What statistical analysis capabilities are required before implementing ILC2 phenotyping?
Robust statistical analysis is needed to interpret flow cytometry data, assess significance of group differences, and validate findings for downstream application in immunology R&D pipelines.
Chapters in this video
0:05
Introduction
1:00
Murine Allergic Rhinitis Model Establishment
2:03
Isolation of Mononuclear Cells from the Nasal Mucosa
4:52
Surface Staining for Flow Cytometry Analysis
6:08
Results: Ovalbumin-Induced Murine Model Development to Explore the Role of ILC2s in Allergic Rhinitis
7:27
Conclusion
